UBS has given positive ratings to Deutsche Bank and Merck KGaA, expressing confidence in the financial and pharmaceutical sectors in Germany.

Deutsche Bank has been rated as a "buy," while Merck KGaA has also received a "buy" rating with a target price of 190 euros, indicating the growth potential of both companies in their respective markets.

In the technology sector, SAP shares have reached a new all-time high after the release of its quarterly figures, with a significant price increase of 2.1%. This positive market response highlights the continued growth within the technology industry.

Furthermore, UBS has released a new analysis of its own shares, suggesting that shareholders need to take immediate action. Investors are advised to evaluate whether it is the right time to buy or sell UBS shares, as outlined in the latest analysis published on October 23.